Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy Siddesh JaimanArun Kumar SharmaDeepa Khanna Review Article 09 August 2013 Pages: 1863 - 1874
Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma Jovan P. AntovicMika SkeppholmRickard E. Malmström Clinical Trial 20 June 2013 Pages: 1875 - 1881
The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers Andrew K. L. GoeyIrma MeijermanJan H. M. Schellens Clinical Trial 24 July 2013 Pages: 1883 - 1890
Elevated risk of opportunistic viral infection in patients with Crohn’s disease during biological therapies: a meta analysis of randomized controlled trials Xiaobing WangFeng ZhouBing Xia Clinical Trial 25 July 2013 Pages: 1891 - 1899
An acenocoumarol dose algorithm based on a South-Eastern European population Tudor Radu PopŞtefan Cristian VesaAnca Dana Buzoianu Pharmacogenetics 18 June 2013 Pages: 1901 - 1907
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study Cinzia CiccacciDavide Di FuscoGiuseppe Liotta Pharmacogenetics 18 June 2013 Pages: 1909 - 1916
PXR polymorphisms and their impact on pharmacokinetics/pharmacodynamics of repaglinide in healthy Chinese volunteers Qing-qing DuZhi-jun WangLing Wang Pharmacogenetics 27 June 2013 Pages: 1917 - 1925
The association between CYP2D6 genotype and switching antipsychotic medication to clozapine Jochem G. GregoorKaren van der WeideEibert R. Heerdink Pharmacogenetics 07 July 2013 Pages: 1927 - 1932
Effect of a single-dose rifampin on the pharmacokinetics of pitavastatin in healthy volunteers Yao ChenWei ZhangHong-Hao Zhou Pharmacokinetics and Disposition 07 July 2013 Pages: 1933 - 1938
A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail Peter N. MorcosLinda ChangJonathan Q. Tran Pharmacokinetics and Disposition 20 July 2013 Pages: 1939 - 1949
Pharmacokinetics of terbutaline in chronic kidney disease Anders BastiansenSarah EggertErland Pedersen Pharmacokinetics and Disposition 31 July 2013 Pages: 1951 - 1954
Persistence to antihypertensive drug treatment in Swedish primary healthcare Miriam QvarnströmThomas KahanBjörn Wettermark Pharmacoepidemiology and Prescription 16 July 2013 Pages: 1955 - 1964
Pharmacoepidemiological characterisation of zolpidem and zopiclone usage Caroline Victorri-VigneauF. FeuilletP. Jolliet Pharmacoepidemiology and Prescription 23 July 2013 Pages: 1965 - 1972
Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment Teresa M. SalgadoBlanca ArguelloFernando Fernandez-Llimos Pharmacoepidemiology and Prescription 25 July 2013 Pages: 1973 - 1979
Towards a single VOICE for European clinical pharmacology: proposals for future developments Jeffrey K. AronsonGiampaolo Velo Conference Report 03 July 2013 Pages: 1981 - 1984
